Medical Aspects of Chemical Warfare (2008) - The Black Vault

Indexchlorine gas attack and, 66Aum Shinrikyochemical attacks against judges, 127–128, 695compared with Al Qaeda, 129sarin attack in the Tokyo subway, 4, 125, 128, 158, 178, 181–182,193, 196–197, 223, 244, 316, 317, 321, 492, 518, 540, 657,695–696, 699, 754Austriacyanogen bromide introduction, 373Aviado, D.incapacitating agent research, 442Aviado, D.M.incapacitating agent research, 442BBabad, H.phosgene research, 345Baille, V.soman-induced brain injury, 224–225Baker, Secretary of War Newton D.Chemical Warfare Service and, 43BAL. See British antilewisiteBalali-Mood, M.mustard exposure research, 313, 315BALF. See Bronchoalveolar lavage fluidBallantyne, B.dibenz[b,f]-1,4-oxazepine research, 467, 468hydrogen cyanide research, 3541-chloroacetophenone research, 460, 4612-chlorobenzylidene malononitrile research, 451Ballough, G.P.soman-induced brain injury, 225Barbiturates. See also specific agentsdescription and incapacitating effects of, 418LSD intoxication treatment, 417safety margin, 418Barlow, R.J.uses of lasers in dermatological practice, 284Basic Personal Equipment, 561Baskin, S.I.cyanide poisoning treatment, 396Bass, Col. SampsonProgram Manager for Demilitarization of Chemical Materieland, 141Basson, Dr. Wouteruse of 3-quinuclidinyl benzilate by Iraq, 413Batrachotoxinchemical structure (figure), 632laboratory findings, 633lethality of, 633mechanism of action, 632monitoring, 633physical examination and, 632–633poison blow gun dart use, 632protection, 633sodium channel effects, 617sources, 632stability, 633surveillance, 633synthesis, 632toxicity, 632treatment, 633Baud, F.J.cyanide poisoning research, 396Baxter Healthcare Corporationplasma-derived human butyrylcholinesterase production, 653BChE. See ButyrylcholinesteraseBehavioral and psychological changescategorization of, 176cyanide poisoning and, 393–394effects of nerve agent exposure, 175–176plasma-derived human butyrylcholinesterase and, 248–249Belgian Consensus on SEstatus epilepticus treatment recommendations, 231Belladonna alkaloids. See Anticholinergic deliriantsBelleau Wood, Battle ofchemical attacks, 29–30overview and detailed maps (exhibit), 28Bellevue Hospital Centerpediatric nerve agent antidote dosing schedule, 684Benzodiazepines. See also specific agentshypothermia and, 548–549incapacitating effects, 420LSD intoxication treatment, 417Berber wardescription, 42–43Berthollet, Comte Claude-Louissynthesis of cyanogen chloride, 116Beswick, F.W.2-chlorobenzylidene malononitrile research, 450Bhopal, Indiaaccidental release of methyl isocyanate, 131, 134, 326, 347Biel, Johnanticholinergic deliriant research, 424Bigeye bombsresearch on, 123, 125bin Laden, Osamaformation of Al Qaeda and, 129September 11, 2001, terrorist attacks and, 65Binary chemical weapons“Bigeye” bomb, 123, 125description, 3, 123development of, 122–124US Congress restrictions on, 124US Congress review of, 124Bing, OscarLSD research, 417Bio Shield towelettesincapacitating agents and, 470–471Biobranemustard agent injury dressing, 280Biological warfareArab-Israeli Six-Day War and, 58“Biotechnology: Impact on Biological Warfare and Biodefense,”420–421chemical weapons comparison, 126Nixon’s ban on biological warfare agents, 138World War I and, 37Biological Weapons Conventiondescription, 137–138Soviet Union and, 61–62Bioregulatorsincapacitating effects, 420–422Bioscavengersadvantages of enzymes, 245catalytic type, 250–251categories of, 245free radical scavengers, 232plasma-derived stoichiometric type, 245–249Project BioShield, 251recombinant stoichiometric type, 249–250“Biotechnology: Impact on Biological Warfare and Biodefense,”420–421Bis-(2-chloroethyl)sulfide. See Mustard agentxxix